Management of Myasthenia Gravis

Medication Considerations

Patients with Myasthenia gravis should avoid Beta-Blockers, IV-Magnesium, Fluorchinolone, Aminoglykoside, and Makrolid-Antibiotika, as these medications can worsen myasthenic symptoms and potentially trigger a myasthenic crisis, according to Praxis Medical Insights 1

Pyridostigminbromid, administered orally two to four times daily, is the first-line treatment for Myasthenia gravis, but approximately half of patients with strabismus-associated Myasthenia show only minimal response, as reported by the American Academy of Ophthalmology 2, 3
Approximately 66% to 85% of patients show a positive response to Corticosteroids, as reported by the American Academy of Ophthalmology 2, 3
Various forms of immunosuppressive therapy with Azathioprin and other agents may be offered by treating neurologists, as reported by the American Academy of Ophthalmology 2, 3
Thymectomy is indicated in some cases, always in the presence of a thymoma, and can significantly reduce symptoms in certain subgroups with Myasthenia gravis, as reported by the American Academy of Ophthalmology 2, 3